Alexandra Wilkis Wilson

Alexandra Wilkis Wilson

Entrepreneur, Executive, Board Director, Investor, Advisor, Mentor, Author, Public Speaker. Alexandra is an innovator and a disruptor. She has established herself as a pioneer, leader, and dealmaker in digital commerce, retail, merchandising, sales, business development and marketing. She has a proven track record building and operating early stage, fast-growing consumer-facing businesses and creating powerful brands.…

Read More

Scott Durbin

Scott Durbin

Scott joined Viveve in early 2013 and became CEO in May 2018. He previously served as the company’s CFO. He is committed to leading Viveve’s clinical and commercial development of its CMRF technology to solidify its position as a global leader in women’s intimate health. Prior to Viveve, he was CFO of publicly traded Aastrom…

Read More

William Meury

William Meury

Mr. Meury is a Partner at Hildred Capital Management, where he currently serves on the Board of Directors for Project Natural, a leading supplier of natural therapeutic consumer healthcare products. Mr. Meury previously served as the Chief Commercial Officer for Allergan from 2015-2020 where he had total P&L responsibility for over 50 products with $16…

Read More

David Amsellem

David Amsellem

David Amsellem is a managing director and senior research analyst at Piper Jaffray covering specialty pharmaceuticals. Prior to joining Piper Jaffray in 2008, David spent five years at Friedman Billings Ramsey, where he was a senior research analyst covering small- and mid-cap pharmaceuticals from 2006-08 and a senior associate on the biotechnology equity research team…

Read More

Irina Erenburg, PhD

Irina Erenburg

Dr. Irina Erenburg is a successful serial entrepreneur with extensive experience in innovation business leadership. She was previously Director of Strategic Transactions at the Partners HealthCare Office of Innovations, Boston’s largest hospital network and a teaching affiliate of Harvard University, and was responsible for high-value deals and startups at MGH — including Zeltiq Aesthetics, which…

Read More

Carrie C. Strom

Carrie Strom is Senior Vice President, AbbVie, and President, Global Allergan Aesthetics and has served in this role since May 2020. Prior to joining AbbVie, Ms. Strom served as Senior Vice President of U.S. Medical Aesthetics at Allergan® beginning in May 2018, overseeing the aesthetic portfolio for the multi-billion dollar U.S. business. Previously, Ms. Strom…

Read More

Tom Albright

Tom Albright

Former Chairman and CEO of Andrew Technologies LLC from 2011 to 2017. In the past, Mr. Albright was President of the topical aesthetic division at Syneron Medical Ltd. and before that Head of North American marketing at Nobel Biocare. From 2000 to 2008, Mr. Albright was VP BOTOX Global Strategic Marketing at Allergan, where he…

Read More

Jeffrey Nugent

Jeffrey Nugent

Jeffrey Nugent joined Sientra in 2014 as a board member, prior to becoming the Chairman and CEO in 2015. Mr. Nugent’s experience includes serving as the CEO and Worldwide President of Neutrogena, where he led the acquisition by Johnson & Johnson. Neutrogena is regarded as one of the most successful acquisitions in J&J history. Following…

Read More

Craig Drill

Craig Drill

Craig A. Drill is the portfolio manager of Craig Drill Capital, a private hedge fund and venture capital group he founded in 1988. He was employed at The First Boston Corporation from 1973 through 1987 and at Burnham and Company from 1969 to 1973. Mr. Drill is a member of the Board of Directors of…

Read More

Aubrey Rankin

Aubrey Rankin

Aubrey is the Co-Founder and CEO of HintMD, Inc., a technology start-up based in Silicon Valley that is bringing dynamic Aesthetic Subscriptions to market through its innovative ExpertCommerce™ Platform. Prior to co-founding HintMD, Aubrey was the Vice President of Asia-Pacific at ZELTIQ Aesthetics. During his time at ZELTIQ, the management team executed on one of…

Read More